1H, 13C NMR, FT-IR, ESI MS and PM5 studies of a new 3,6,9-trioxadecylamide of monensin A and its complexes with Li+, Na+ and K+ cations

[1]  B. Brzeziński,et al.  Spectroscopic, semi-empirical and antimicrobial studies of a new amide of monensin A with 4-aminobenzo-15-crown-5 and its complexes with Na⁺ cation at 1:1 and 1:2 ratios , 2011 .

[2]  B. Brzeziński,et al.  Crystal structure and FT-IR study of aqualithium 1-naphthylmethyl ester of monensin A perchlorate , 2011 .

[3]  B. Brzeziński,et al.  Structural characterization and antibacterial activity against clinical isolates of Staphylococcus of N-phenylamide of monensin A and its 1:1 complexes with monovalent cations. , 2010, European journal of medicinal chemistry.

[4]  M. Mitewa,et al.  Nickel(II) and zinc(II) dimonensinates: Single crystal X-ray structure, spectral properties and bactericidal activity , 2010 .

[5]  M. Mitewa,et al.  First solid state alkaline-earth complexes of monensic acid A (MonH): crystal structure of [M(Mon)2(H2O)2] (M = Mg, Ca), spectral properties and cytotoxicity against aerobic Gram-positive bacteria , 2010, BioMetals.

[6]  B. Brzeziński,et al.  Syntheses, structural and antimicrobial studies of a new N-allylamide of monensin A and its complexes with monovalent metal cations , 2009 .

[7]  A. Katrusiak,et al.  Structural and antimicrobial studies of a new N-phenylamide of monensin A complex with sodium chloride , 2009 .

[8]  A. Katrusiak,et al.  Molecular structure of rubidium six-coordinated dihydrate complex with monensin A , 2008 .

[9]  Iris M. Oppel,et al.  First divalent metal complexes of the polyether ionophore Monensin A: X-Ray structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their bactericidal properties. , 2008, Current drug discovery technologies.

[10]  B. Brzeziński,et al.  Spectroscopic, mass spectrometry, and semiempirical investigations of a new 2-(2-methoxyethoxy)ethyl ester of Monensin A and its complexes with monovalent cations , 2008 .

[11]  B. Brzeziński,et al.  Synthesis and antimicrobial properties of monensin A esters. , 2008, Bioorganic & medicinal chemistry letters.

[12]  B. Brzeziński,et al.  NMR, FTIR, ESI-MS and semiempirical study of a new 2-(2-hydroxyethoxy)ethyl ester of monensin A and its complexes with alkali metal cations , 2007 .

[13]  A. Katrusiak,et al.  Molecular structure of the 1:1 inclusion complex of monensin A lithium salt with acetonitrile , 2007 .

[14]  B. Brzeziński,et al.  The structures of monensin A derivatives and its complexes with some monovalent cations studied by the AM1d, PM3 as well as PM5 semiempirical methods , 2007 .

[15]  Alfredo Mayall Simas,et al.  RM1: A reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I , 2006, J. Comput. Chem..

[16]  Mandip Singh,et al.  Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin‐resistant human breast tumour (MCF‐7/dox) cell‐line , 2004, The Journal of pharmacy and pharmacology.

[17]  F. Haesebrouck,et al.  Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria , 2003, Clinical Microbiology Reviews.

[18]  J. Staunton,et al.  Fragmentation studies on monensin A by sequential electrospray mass spectrometry. , 2002, The Analyst.

[19]  Hui Hong,et al.  Fragmentation studies on monensin A and B by accurate-mass electrospray tandem mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[20]  M. Dacasto,et al.  Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. , 2002, Journal of veterinary pharmacology and therapeutics.

[21]  A. Nagatsu,et al.  Studies on chemical modification of monensin. Part 7: Synthesis and Ca2+ ion transport activity of 25-carboxylmonensin , 2000 .

[22]  R. Julian,et al.  Electrospray ionization mass spectrometry with in-source collision-induced dissociation of monensin factors and related metabolites , 1998 .

[23]  M. Khan.  Kinetic Evidence for the Occurrence of a Stepwise Mechanism in the Hydrazinolysis of Phthalimide , 1995 .

[24]  Y. Hatano,et al.  Monensin-mediated antiport of Na+ and H+ across liposome membrane. , 1991, Biochimica et biophysica acta.

[25]  J. Stewart.  Optimization of parameters for semiempirical methods. III Extension of PM3 to Be, Mg, Zn, Ga, Ge, As, Se, Cd, In, Sn, Sb, Te, Hg, Tl, Pb, and Bi , 1991 .

[26]  W. Pangborn,et al.  The hydrated potassium complex of the ionophore monensin A , 1987 .

[27]  M. Novilla,et al.  Comparative toxicology of monensin sodium in laboratory animals. , 1984, Journal of animal science.

[28]  D. Droumev.  Review of antimicrobial growth promoting agents available , 1983, Veterinary Research Communications.

[29]  M. Fahim,et al.  Cardiovascular effects and pharmacokinetics of the carboxylic ionophore monensin in dogs and rabbits. , 1981, Life sciences.

[30]  A. I. Popov,et al.  Solution chemistry of monensin and its alkali metal ion complexes. Potentiometric and spectroscopic studies , 1975 .

[31]  C. Sheu,et al.  Inhibitory Effects of Lipophilic Acids and Related Compounds on Bacteria and Mammalian Cells , 1975, Antimicrobial Agents and Chemotherapy.

[32]  C. A. Grob.  Mechanisms and Stereochemistry of Heterolytic Fragmentation , 1969 .

[33]  L. Steinrauf,et al.  The structure of monensic acid, a new biologically active compound. , 1967, Journal of the American Chemical Society.

[34]  P. Wharton,et al.  Fragmentation of 1,10-Decalindiol Monotosylates1 , 1965 .

[35]  B. Gierczyk,et al.  FTIR and multinuclear magnetic resonance studies of tris(oxaalkyl) borates and their complexes with Li+ and Na+ cations , 1999 .

[36]  A. I. Popov,et al.  A study of metal complexes of a naturally occurring macrocyclic ionophore-monensin , 1979 .

[37]  B. Pressman,et al.  Biological applications of ionophores. , 1976, Annual review of biochemistry.

[38]  Shumard Rf,et al.  Monensin, a new biologically active compound. VI. Anticoccidial activity , 1967 .